Point72 (Difc) LTD Day One Biopharmaceuticals, Inc. Transaction History
Point72 (Difc) LTD
- $2.72 Trillion
- Q4 2024
Shares
2 transactions
Others Institutions Holding DAWN
# of Institutions
181Shares Held
79.7MCall Options Held
130KPut Options Held
217K-
Atlas Venture Life Science Advisors, LLC6.43MShares$78.8 Million13.44% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.85MShares$71.7 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.76MShares$70.6 Million1.18% of portfolio
-
Braidwell LP Stamford, CT4.87MShares$59.8 Million3.46% of portfolio
-
Black Rock Inc. New York, NY4.53MShares$55.6 Million0.0% of portfolio
About Day One Biopharmaceuticals, Inc.
- Ticker DAWN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,461,104
- Market Cap $901M
- Description
- Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...